Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R

This study examined if the Fisetin against streptozotocin-induced diabetic cardiomyopathy (DC) in rats involves regulating cardiac metabolism and suppressing protein kinase R (PKR). Male rats were divided (12/groups) as control (non-diabetic), control + Fisetin, T1DM, and T1DM + Fisetin. Fisetin was...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Saudi Pharm J
Glavni autori: ALTamimi, Jozaa Z., BinMowyna, Mona N., AlFaris, Nora A., Alagal, Reham I., El-kott, Attalla F., AL-Farga, Ammar M.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2021
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873759/
https://ncbi.nlm.nih.gov/pubmed/33603537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2020.12.003
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items